BROSSARD, QUEBEC — (Marketwired) — 11/19/14 — DIAGNOS Inc. (“DIAGNOS” or “the Corporation”) (TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today the resignation of Mr. Olivier Lerolle as a director and Chairman of the audit committee of DIAGNOS. Mr. Lerolle is resigning from the DIAGNOS Board for health and personal reasons.
“On behalf of my fellow members of the board, I sincerely thank Olivier for his significant contributions during his time with us. Olivier has been a director of DIAGNOS for over ten years and was a key asset in the development of the Corporation. We wish Olivier all the very best in these personal and challenging times,” said Mr. Philip Renaud, Chairman of the board.
About DIAGNOS
Founded in 1998, DIAGNOS is a publicly traded Canadian corporation with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including natural resources, healthcare, and entertainment.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
Andre Larente, President
(450) 678-8882, ext.: 224
You must be logged in to post a comment Login